However, we identified neither correlations between frequencies of classical circulating CD4+ or CD8+ T-cells lacking CD56 expression, nor their PD-1+ fractions with outcome after therapy, although these populations may contain tumor-reactive cells[35,38]. This evidence concerns the gene CD4 and neoplasm.